Crystal structure of drug resistant SRC kinase domain with irreversible inhibitor
The structure was published by Michalczyk, A., Kluter, S., Rode, H.B., et al., Grutter, C., Rabiller, M., and Rauh, D., in 2008 in a paper entitled "Structural insights into how irreversible inhibitors can overcome drug resistance in EGFR." (abstract).
This crystal structure was determined using X-ray diffraction at a resolution of 2.38 Å and deposited in 2007.
The experimental data on which the structure is based was also deposited.
This PDB entry contains multiple copies of the structure of Proto-oncogene tyrosine-protein kinase Src.
It also contains one or more heterogenic compounds (e.g., ligands, co-factors, ions, modified amino acids, etc.); see here for a complete list.
The molecule has more than one probable quaternary state observed. For more details see the quaternary structure page.
The following tables show cross-reference information to other databases (to obtain a list of all PDB entries sharing the same property or classification, click on the magnifying glass icon):
This entry contains 1 unique UniProt protein: